Antineoplastic Combined Chemotherapy ProtocolsChemotherapy, AdjuvantCombined Modality TherapyAntineoplastic AgentsRadiation DosageRadiation, IonizingCisplatinRadiation InjuriesCyclophosphamideDoxorubicinTreatment OutcomeDose-Response Relationship, RadiationNeoadjuvant TherapyDisease-Free SurvivalBreast NeoplasmsRadiation ToleranceNeoplasm StagingEtoposideSurvival AnalysisRadiationSurvival RatePrognosisDrug Administration ScheduleLung NeoplasmsRadiation ProtectionMethotrexateRadiotherapyRadiation MonitoringCarboplatinNeoplasm Recurrence, LocalPaclitaxelVinblastineInduction ChemotherapyNeoplasmsTaxoidsRadiotherapy DosageDrug Resistance, NeoplasmBleomycinIfosfamideDeoxycytidineRadiotherapy, AdjuvantAntimetabolites, AntineoplasticOrganoplatinum CompoundsFollow-Up StudiesAntineoplastic Agents, AlkylatingCarcinoma, Non-Small-Cell LungTime FactorsSalvage TherapyAnthracyclinesRadiation OncologyCytarabineAdenocarcinomaChemotherapy, Cancer, Regional PerfusionNeoplasm MetastasisOvarian NeoplasmsHodgkin DiseaseBrain NeoplasmsLymphoma, Non-HodgkinTesticular NeoplasmsVomitingNeutropeniaTransplantation, AutologousAntineoplastic Agents, PhytogenicRadiation PneumonitisNauseaDacarbazineColorectal NeoplasmsProspective StudiesClinical Trials as TopicRadiation Injuries, ExperimentalAntibiotics, AntineoplasticKaplan-Meier EstimateCosmic RadiationLomustineCarmustineNeoplasms, Radiation-InducedCell Line, TumorBone NeoplasmsNeoplasms, Germ Cell and EmbryonalCarcinoma, Squamous CellCamptothecinGranulocyte Colony-Stimulating FactorPlatinum CompoundsGamma RaysOsteosarcomaChemoradiotherapyLeukopeniaInfusions, Intra-ArterialDose-Response Relationship, DrugLiver NeoplasmsTumor Markers, BiologicalMelphalanLymphatic MetastasisHead and Neck NeoplasmsPalliative CareAntiemeticsRecurrenceCranial IrradiationInfusions, IntravenousThiotepa